Clinical trial
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With…
NCT00048061 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048061 |
|---|---|
| Title | MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis |
| Official title | Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post Menopausal Osteoporosis |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Ibandronate [Bonviva/Boniva], Calcium, Vitamin D |
| Enrollment | 1,609 |
| Start date | Apr 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Oct 25, 2002 |
| Last update posted | Mar 29, 2018 |
| Countries | Australia, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, Italy, Mexico, Norway and 7 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: